Wang Hao, Gu Zhitao, Ding Jianyong, Tan Lijie, Fu Jianhua, Shen Yi, Wei Yucheng, Zhang Peng, Han Yongtao, Chen Chun, Zhang Renquan, Li Yin, Chen Ke-Neng, Chen Hezhong, Liu Yongyu, Cui Youbing, Wang Yun, Pang Liewen, Yu Zhentao, Zhou Xinming, Liu Yangchun, Liu Yuan, Fang Wentao
Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China.
Zhongguo Fei Ai Za Zhi. 2016 Jul 20;19(7):453-8. doi: 10.3779/j.issn.1009-3419.2016.07.07.
Video-assisted thoracoscopic surgery (VATS) theoretically offers advantages over open thymectomy for clinically early-stage (Masaoka-Koga stage I and II) thymic malignancies. However, longterm outcomes have not been well studied. We compared the postoperative outcomes and survival from a cohort study based on the database of the Chinese Alliance for Research in Thymomas (ChART).
Between 1994 and 2012, data of 1,117 patients having surgery for clinically early-stage (Masaoka-Koga stage I and II) tumors were enrolled for the study. Among them, 241 cases underwent VATS thymectomy (VATS group), while 876 cases underwent open thymectomy (Open group). Univariate analyses were used to compare the clinical character and perioperative outcomes between the two groups. And multivariate analysis was performed to determine the independent predictive factors for long-term survival.
Compared with the Open group, the VATS group had higher percentage of total thymectomy (80.5% vs 73.9%, P=0.028), resection rate (98.8% vs 88.7%, P<0.001) and less recurrence (2.9% vs 16.0%, P<0.001). Five-year overall survival was 92% after VATS and 92% after open thymectomy, with no significant difference between the two groups (P=0.15). However, 5-year disease free survival were 92% in VATS group and 83% in Open group (P=0.011). Cox proportional hazards model revealed that WHO classification, Masaoka-Koga stage and adjuvant therapy were independent predictive factors for overall survival, while surgical approach had no significant impact on long-term outcome.
CONCLUSIONS: This study suggests that VATS thymectomy is an effective approach for clinically early-stage thymic malignancies. And it may offer better perioperative outcomes, as well as equal oncological survival. .
对于临床早期(马萨oka - 古贺分期I和II期)胸腺恶性肿瘤,电视辅助胸腔镜手术(VATS)理论上比开放性胸腺切除术具有优势。然而,长期结果尚未得到充分研究。我们基于中国胸腺瘤研究联盟(ChART)的数据库进行队列研究,比较了术后结果和生存率。
1994年至2012年间,纳入1117例因临床早期(马萨oka - 古贺分期I和II期)肿瘤接受手术的患者数据进行研究。其中,241例接受VATS胸腺切除术(VATS组),876例接受开放性胸腺切除术(开放组)。采用单因素分析比较两组的临床特征和围手术期结果。并进行多因素分析以确定长期生存的独立预测因素。
与开放组相比,VATS组全胸腺切除术的比例更高(80.5%对73.9%,P = 0.028),切除率更高(98.8%对88.7%,P < 0.001),复发更少(2.9%对16.